BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AG
Strengthens Remote Patient Monitoring Platform
Pre-Announcement of the Public Tender Offer by BioTelemetry, Inc. for LifeWatch AG Shares
Available in English, German, and French
BioTelemetry, Inc. Announces Acquisition of Telcare’s Remote Diabetes Management Platform
Extends reach into rapidly expanding digital population health management market
Leading the Advancement of Remote Patient Monitoring
The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. At BioTelemetry, we fuel the advancement of mobile health services by providing leading technology and services that help healthcare providers monitor and diagnose patients and clinical research subjects in a more efficient, accurate, and cost-effective manner.
1 Million Patients Monitored Wirelessly
At BioTelemetry, we are raising mobile health to new heights. As a pioneer in remote patient monitoring, we revolutionized the healthcare industry with the first Mobile Cardiac Outpatient Telemetry™ system. Today, we have monitored over 1 million patients wirelessly. You might say, we put the “m” (million) in mHealth.
The World’s Largest Cardiac Data Network
Processing over 2 billion heartbeats a day, while supporting over 20,000 sites, and monitoring over 500,000 patients a year.
0
+
Processing over 2 billion heartbeats a day
0
+
Provided over 1 million reports to physicians with information for diagnosis and therapy management
0
+
Monitoring over 500,000 patients a year
0
+
Over 50,000 monitoring devices — 29 U.S. patents and 34 international patents issued
0
+
Supporting more than 20,000 physicians and sites
$
0
+
Over $300 million invested in the technology and service platform
